You are not currently logged in.
Log in
Morning after pills
What is the morning-after pill?
The morning-after pill is intended for use up to 72 hours after sex
which may lead to pregnancy. The morning-after pill most commonly used
in Britain is called Levonelle-2.
How does it work?
The morning-after pill can act as a contraceptive by stopping ovulation
and therefore preventing fertilisation. It may also alter the motility
of sperm in the fallopian tube and prevent it from meeting the egg. The
morning-after pill can also act as an early abortifacient. It attacks
the womb's lining, so that if fertilisation has already taken place the
newly-created embryo is unable to implant.
How can a woman tell which effect the drug has had?
She cannot tell. One of the difficulties a woman faces after taking the
morning-after pill is that she will probably never know whether it
caused an abortion or not. Pregnancy tests cannot detect the embryo
until after implantation. If conception occurs followed by an early
abortion, the embryo will not be identifiable in the menstrual loss.
What is contained in the morning-after pill?
The morning-after pill is a progestogen-only pill that contains up to
50 times the daily dosage of progestogen found in the ordinary
mini-pill. Progestogen is a synthetic copy of the natural female
hormone progesterone.
The morning-after pill: Ethical or not?
Describing the morning-after pill as "emergency contraception" is
misleading. Sometimes the morning-after pill will work as an
abortifacient.
Where fertilisation has already occurred the morning-after pill will
typically result in the loss of human life, as the newly created embryo
cannot survive when he/she is prevented from implanting in the womb.
If the morning-after pill fails to prevent pregnancy or cause an early
abortion, there is a risk of an ectopic pregnancy developing (where the
embryo implants outside the womb). Where there is an ongoing pregnancy,
1 in 20 cases will be ectopic. This is a life-threatening condition.
Where there is no ectopic pregnancy and the embryo continues to develop
there is a risk of disabling conditions arising.
There have been no trials on the long-term effects of the morning-after
pill and no published trials on its effects on the fertility and health
of teenage girls. The morning-after pill is being increasingly
promoted, particularly to girls under the age of consent. The effects
on women's health are not being monitored, despite the fact that the
drug company behind it recommends that the morning-after pill is not
given to girls under 16 without the supervision of their doctor.
In spite of the huge increase in the provision of the morning-after
pill since the early 1990s, there has been no comparable decrease in
the number of registered abortions or teenage pregnancies, despite the
early abortions it causes. Its promotion is more likely to encourage
risk-taking behaviour and sexual
promiscuity. In this way it also exacerbates the spread of sexually
transmitted diseases, as it offers no protection against these.
Promotion of the morning-after pill is entirely unethical.